KR20040079189A - Method for production of cloned animal embryos by nuclear transfer - Google Patents

Method for production of cloned animal embryos by nuclear transfer Download PDF

Info

Publication number
KR20040079189A
KR20040079189A KR1020030014132A KR20030014132A KR20040079189A KR 20040079189 A KR20040079189 A KR 20040079189A KR 1020030014132 A KR1020030014132 A KR 1020030014132A KR 20030014132 A KR20030014132 A KR 20030014132A KR 20040079189 A KR20040079189 A KR 20040079189A
Authority
KR
South Korea
Prior art keywords
oocyte
egg
nucleus
cell
somatic
Prior art date
Application number
KR1020030014132A
Other languages
Korean (ko)
Other versions
KR100500412B1 (en
Inventor
박광욱
박창식
설재구
허기남
Original Assignee
(주)엠젠바이오
박광욱
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)엠젠바이오, 박광욱 filed Critical (주)엠젠바이오
Priority to KR10-2003-0014132A priority Critical patent/KR100500412B1/en
Publication of KR20040079189A publication Critical patent/KR20040079189A/en
Application granted granted Critical
Publication of KR100500412B1 publication Critical patent/KR100500412B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/873Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
    • C12N15/877Techniques for producing new mammalian cloned embryos
    • C12N15/8778Swine embryos
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00Rearing or breeding animals, not otherwise provided for; New breeds of animals
    • A01K67/027New breeds of vertebrates
    • A01K67/0273Cloned animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61DVETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
    • A61D19/00Instruments or methods for reproduction or fertilisation
    • A61D19/04Instruments or methods for reproduction or fertilisation for embryo transplantation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N13/00Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10Cells modified by introduction of foreign genetic material
    • C12N5/12Fused cells, e.g. hybridomas
    • C12N5/16Animal cells
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00Animals characterised by species
    • A01K2227/10Mammal
    • A01K2227/108Swine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2517/00Cells related to new breeds of animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Environmental Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Transplantation (AREA)
  • Reproductive Health (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

PURPOSE: A method for production of cloned animal embryos by nuclear transfer is provided to reduce the number of cloning processes. Therefore, itt can be useful for preservation of animals threatened with extinction, production of useful proteins, development of disease model, and supply of deficient organs. CONSTITUTION: The method for production of cloned animal embryos by nuclear transfer comprises the steps of: (i) inhaling a first polar body and 10 to 20% of cytoplasm without dying the nuclear of an egg cell by using a glass pipe having diameter of 20 to 40 micrometer to remove the nuclear from the egg cell; (ii) introducing a somatic cell into the first polar body and nuclear removed egg cell to prepare an egg-somatic cell complex within 1 minute during the inhalation process; and (iii) subjecting the egg-somatic cell complex to electric stimulation of 0.5 to 2 kv/cm and 6 to 150 microseconds 1 to 3 times to fuse and activate the egg-somatic cell complex, wherein the egg cell is collected from a mammal selected from pig, cow, sheet, mouse, rat, rabbit, dog and cat.

Description

핵이식에 의한 동물의 복제란 제조방법{Method for production of cloned animal embryos by nuclear transfer}BACKGROUND OF THE INVENTION 1. Field of the Invention [0001] The present invention relates to a method for producing a cloned animal embryo by nuclear transfer,

본 발명은 핵이식에 의한 동물의 복제란 제조방법에 관한 것으로서, 보다 상세하게는 난자의 제 1 극체와 핵을 제거하고, 난자의 위란강에 체세포를 주입하여 세포융합 및 활성화를 시키는 단계를 포함하는 복제란을 제조하는 방법에 관한 것이다.The present invention relates to a method for producing an animal clone by nuclear transfer, and more particularly, to a method for producing an animal clone by nuclear transfer, comprising the steps of removing the first polar body and nucleus of an oocyte and injecting somatic cells into the egg- To a method for producing a clone.

복제(cloning)는 유전적으로 동일한 개체를 만드는 것으로써 핵이식(nuclear transfer)은 진핵생물에 있어서의 복제의 한 방법으로 최근 분자생물학의 급격한 발달로 새로이 주목받게된 기술이다. 초기의 핵이식은 핵의 공급원으로 수정란의 할구를 이용하였으나(Prather,et al.,Biol. Reprod., 1987, 37:856-866; Prather,et al.,Biol. Reprod., 1989, 41:414-418), 최근에는 체세포의 핵을 이용하게 되었다.Cloning is genetically identical, and nuclear transfer is a new method of replication in eukaryotes that has recently come to the fore with the rapid development of molecular biology. Early nuclear transfer has been used as a source of nuclear fertilized eggs (Prather et al ., Biol. Reprod. , 1987, 37: 856-866; Prather et al ., Biol. Reprod. , 1989, 414-418). Recently, somatic cell nuclei have been used.

체세포 복제는 분화된 체세포를 핵이 제거된 난자에 넣어 활성화시킨 다음에 일반 수정란과 동일한 방법으로 발생시키는 기술이다. 이와 같은 복제기술은 발생생물학 분야를 비롯한 기초과학 분야의 연구에 널리 이용될 수 있을 뿐만 아니라 유용 단백질의 생산, 질환 모델의 개발 및 장기 이식 분야 등 다양한 의학 및 의약 분야에 크게 기여할 것으로 예상되어 그 산업적 이용성이 매우 크다고 할 수 있다.Somatic replication is a technique in which differentiated somatic cells are activated by putting them into a nucleus-free oocyte and then generated in the same way as normal embryos. Such replication technology is expected to be widely used for research in basic science including developmental biology, and is expected to contribute greatly to various medical and pharmaceutical fields such as production of useful protein, development of disease model, and organ transplantation. It can be said that the usability is very high.

최초의 체세포 복제 동물인 돌리(Willmut, I.et al.,Nature, 1997, 385:810-813) 양이 탄생한 이후, 체세포 복제 분야는 많은 발전을 거듭하여 소(Cibelli, JB.et al.,Science, 1998, 280:1256-1258; Wells, DN.et al.,Reprod. Fertil. Dev., 1998, 10:369-378), 생쥐(Wakayama, T.et al.,Nature,1998, 394:369-374), 산양(Bagusi, A.et al.,Nat. Biotechnol., 1999, 17:456-461) 등의 복제에 성공을 하게 되었다. 그러나, 돼지는 다른 종에 비하여 수정란에 대한 연구가 상대적으로 적게 이루어졌고, 최소한 4마리의 태아가 자궁에 착상해야만 임신이 유지되는 생리적 특성 등 여러 가지 어려움 때문에 주요 가축 중에서는 늦게 복제에 성공을 하게 되었다(Poleajaeva, IA.et al.,Nature, 2000, 407:86-90; Onishi, A.et al.,Science, 2000, 289:1188-1190; Betthauser, J.et al.,Nat. Biotechnol., 2000, 18:1055-1059). 그 후, 돼지 체세포에 외부 유전자를 주입시켜 복제에 성공함으로써 최초의 형질전환 복제 돼지가 탄생하였고(Park, KW.et al.,Anim. Biotechnol., 2001, 12:173-181), 특정유전자를 체세포에서 유전자결손(knockout)시킨 복제돼지도 성공하였다(Lai, L.et al., Nat. Biotechnol., 2002 Mar, 20(3):251-255). 그러나, 돼지 체세포 복제 분야의 급속한 발전에도 불구하고 아직도 복제의 효율은 1-5%로 낮아 효율을 개선시키기 위한 많은 연구가 진행중이다.Dolly, the first animal cloning. (Willmut, I. et al, Nature, 1997, 385:. 810-813) after the amount of birth, cloning cows in the field continued to develop many (Cibelli, JB et al. , Science, 1998, 280: 1256-1258 ; Wells, DN et al, Reprod Fertil Dev, 1998, 10:...... 369-378), mice (Wakayama, T. et al, Nature , 1998, 394 : 369-374), goat (Bagusi, A. et al ., Nat. Biotechnol ., 1999, 17: 456-461). However, pigs have had relatively few studies on fertilized eggs compared to other species, and at least four embryos have to be implanted in the uterus to survive cloning, was (Poleajaeva, IA et al, Nature , 2000, 407: 86-90; Onishi, A. et al, Science, 2000, 289:..... 1188-1190; Betthauser, J. et al, Nat Biotechnol. , 2000, 18: 1055-1059). After that, the first transgenic cloned pig was born by transplanting an exogenous gene into pig somatic cells and succeeded in cloning (Park, KW et al ., Anim. Biotechnol ., 2001, 12: 173-181) Reproduction piglets that have knocked out somatic cells have also been successful (Lai, L. et al., Nat. Biotechnol. , 2002 Mar. 20 (3): 251-255). However, despite the rapid development of pig somatic cell replication, replication efficiency is still low at 1-5%, and many studies are under way to improve efficiency.

체세포 복제 기술 중에서 핵심이 되는 기술은 핵이식 과정에서 체세포를 난자의 위강란에 주입하기에 앞서서, 난자의 핵을 제거하는 과정에 있다. 난자의 핵을 제거하기 위해서는 헥스트(hoechst) 33342라는 형광염색을 일반적으로 이용하고 있다. 즉, 난자를 헥스트 33342로 염색한 후 자외선(UV) 하에서 난자의 핵을 제거한다. 이때, 상기 형광염색이나 자외선에의 노출은 핵이식란의 발생에 영향을 줄 가능성이 높으며(Tao, T.et al.,Zygote, 2000, 8:69-77), 이러한 복잡한 과정은복제를 하는 연구자에게도 많은 피로를 야기시켜 복제란의 제조 효율을 감소시키는 요인이 되고 있다.The key technology in somatic cell replication technology is the process of removing the nucleus of the egg prior to injecting somatic cells into the stomach of the oocyte during nuclear transfer. Fluorescent staining, hoechst 33342, is commonly used to remove the nucleus of the oocyte. That is, oocytes are stained with Hest 33342, and the oocyte nuclei are removed under ultraviolet light (UV). At this time, the fluorescent staining or exposure to ultraviolet light is likely to affect the development of nuclear transfer embryos (Tao, T. et al ., Zygote , 2000, 8: 69-77) Causing a great deal of fatigue, thereby decreasing the production efficiency of the cloned cells.

본 발명은 상기와 같은 문제점을 해결하기 위하여 안출된 것으로서, 형광염색 및 자외선을 이용하지 않고도 핵을 제거하고 난자와 체세포의 융합 이후에 부가적인 활성화 자극 없이도 복제란을 활성화시킴으로써 핵이식 과정을 단순화시킬 수 있는 고효율의 체세포 복제방법을 제공하는 것을 목적으로 한다.Disclosure of the Invention The present invention has been conceived to solve the above problems. It is an object of the present invention to simplify the nuclear transfer process by removing the nucleus without using fluorescent staining and ultraviolet rays and activating the cloning column without additional activation stimulation after oocyte and somatic cell fusion The present invention also provides a method for cloning somatic cells with high efficiency.

도 1은 형광염색을 통하지 않고 난자에서 핵을 제거하는 방법을 보여주는 사진이고, 1 is a photograph showing a method of removing nuclei from an egg without going through fluorescent staining,

ⓐ 난자의 극체를 1시 방향으로 고정,Ⓐ Fix the polar body of egg to 1 o'clock position,

ⓑ 극체를 중심으로 약 10 내지 20% 세포질의 제거,Ⓑ About 10-20% removal of cytoplasm around the polar body,

ⓒ 핵을 제거하고 체세포를 위란강에 삽입,Ⓒ Remove the nucleus and insert somatic cells into the urean steel,

ⓓ 체세포가 위강란에 삽입된 모습Ⓓ Somatic cells are inserted in the stomach

도 2는 복제란을 6일간 배양한 후 핵을 염색한 사진이다. Fig. 2 is a photograph showing the nucleus stained after the cloning column was cultured for 6 days.

ⓐ 일반 현미경 사진,Ⓐ general microscope photograph,

ⓑ 형광염색 후의 형광현미경 사진Ⓑ fluorescence microscope photograph after fluorescence staining

상기 목적을 달성하기 위하여, 본 발명은 ⅰ) 난자의 핵을 염색하지 않고 제 1 극체와 10 내지 20%의 세포질을 흡입(suction)하여 난자의 핵을 제거하는 단계; ⅱ) 제 1 극체와 핵을 제거한 상기 난자의 위란강에 체세포를 주입하여 난자-체세포 복합체를 제조하는 단계; 및 ⅲ) 0.5 내지 2 ㎸/㎝, 6 내지 150 ㎲로 1 내지 3회 시행하는 전기적 자극으로 상기 난자-체세포 복합체를 세포융합 및 활성화시키는 단계를 포함하는 동물의 복제란 제조방법을 제공한다.In order to accomplish the above object, the present invention provides a method for removing oocytes, comprising the steps of: i) removing the nucleus of an oocyte by suctioning the first polar body and 10-20% of the cytoplasm without staining the nucleus of the oocyte; Ii) injecting a somatic cell into the proliferation of the oocyte in which the first polar body and the nucleus are removed to prepare an oocyte-somatic cell complex; And iii) cell fusion and activation of the oocyte-somatic cell complex by electrical stimulation conducted at 0.5 to 2 kV / cm and 6 to 150 1 for 1 to 3 times.

상기에서 "극체"는 난자가 수정 전 제2 감수분열에 의하여 난세포질의 일부가 분열하여 나온 돌기를 가리키며(도 1 참조),"위란강"은 난자의 투명대와 난세포질 사이의 공간을 가리킨다. 또한, "난자-체세포 복합체"는 난자의 핵을 제거한후 체세포를 위란강에 주입하고 세포융합이 일어나기 전 단계를 가리키며, "복제란"은 전기적 자극에 의하여 난자와 체세포가 융합된 단계를 가리킨다.The term "polar body" refers to a protrusion of a part of ovarian cells separated by an oocyte by the second meiosis before fertilization (see Fig. 1), and the "Yurian River " refers to a space between the oocyte's zona pellucida and the cytoplasm. In addition, "oocyte-somatic cell complex" refers to a stage in which somatic cells are injected into the rabbits after oocyte nuclei are removed, before the cell fusion occurs, and "cloned cells " refers to a stage where oocytes and somatic cells are fused by electrical stimulation.

이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.

본 발명의 복제란 제조방법은 ⅰ) 난자의 핵을 염색하지 않고 제 1 극체와 10 내지 20%의 세포질을 흡입하여 난자의 핵을 제거하는 단계; ⅱ) 제 1 극체와 핵을 제거한 상기 난자의 위란강에 체세포를 주입하여 난자-체세포 복합체를 제조하는 단계; 및 ⅲ) 0.5 내지 2 ㎸/㎝, 6 내지 150 ㎲로 1 내지 3회 시행하는 전기적 자극으로 상기 난자-체세포 복합체를 세포융합 및 활성화시키는 단계를 포함한다.The replication method of the present invention comprises the steps of: i) removing the nucleus of the oocyte by inhaling the first polar body and 10-20% of the cytoplasm without staining the nucleus of the oocyte; Ii) injecting a somatic cell into the proliferation of the oocyte in which the first polar body and the nucleus are removed to prepare an oocyte-somatic cell complex; And iii) 0.5 to 2 kV / cm, 6 to 150 1 for 1 to 3 times to effect cell fusion and activation of the oocyte-somatic cell complex.

상기에서 단계 ⅰ)의 흡입은 직경 20-40 ㎛, 30-60°의 선단 구조인 유리관을 사용하여 유압 차를 이용하여 이루어지는 것이 바람직하다.It is preferable that the inhalation of step i) is carried out using a hydraulic pressure difference using a glass tube having a diameter of 20-40 mu m and a tip structure of 30-60 DEG.

구체적으로, 본 발명의 실시예에서와 같이 먼저 난자의 극체를 1시 방향으로 고정시키고 30-60°로 날카롭게 연마한 미세유리관을 극체가 있는 방향으로 찔러 넣는다. 유압을 이용하여 극체와 극체 주위의 세포질을 약 10 내지 20% 정도 흡입한다. 이때, 대부분의 핵은 극체 주위에 위치해 있으므로 상기 과정에서 난자의 핵의 대부분이 제거된다.Specifically, as in the embodiment of the present invention, the oocyte's polar body is first fixed at 1 o'clock position, and the micro-glass tube sharpened at 30-60 DEG is pushed in the polar body direction. By using the hydraulic pressure, the cytoplasm around the polar body and the polar body is inhaled by about 10 to 20%. At this time, since most of the nuclei are located around the polar body, most of the nuclei of the oocyte are removed in the above process.

또한, 단계 ⅰ)에 있어서 복제란을 제조하기 위한 난자는 인간을 제외한 포유동물로부터 채취되는 것이 바람직하고, 돼지, 소, 산양, 생쥐(mouse),큰쥐(rat), 토끼, 개, 고양이로 구성되는 군으로부터 선택되는 한 종인 것이 더욱 바람직하다. 또한, 복제 대상인 체세포는 인간을 제외한 포유동물로부터 채취되는 것이 바람직하고, 돼지, 소, 산양, 생쥐, 큰쥐, 토끼, 개, 고양이로 구성되는 군으로부터 선택되는 한 종인 것이 더욱 바람직하며, 돼지인 것이 가장 바람직하다.In addition, in step i), the egg for producing the cloned egg is preferably collected from a mammal other than a human, and is preferably composed of a pig, a cow, a goat, a mouse, a rat, a rabbit, And more preferably selected from the group consisting of The somatic cells to be cloned are preferably collected from mammals other than humans, and more preferably selected from the group consisting of pigs, cows, goats, mice, mice, rabbits, dogs and cats, Most preferred.

또한, 단계 ⅱ)에 있어서 난자의 핵을 제거한 후 1분 내에 체세포를 주입하는 것이 바람직하다.In addition, in step ii), it is preferable to inject somatic cells within one minute after removing the nucleus of the oocyte.

종래기술에서는 핵이식에 사용될 모든 난자의 핵을 제거한 후 체세포 주입에 들어가므로, 난자의 핵을 제거하는 데 소요되는 시간이 약 1-3시간 이 소요된 이후에 체세포의 주입에 들어간다. 그러나, 본 발명은 난자의 핵 제거 후 바로 체세포 주입과정을 진행하므로 그 시간을 1분 내로 줄일 수 있다.In the prior art, since the nuclei of all the oocytes to be used for nuclear transfer are removed and then the somatic cells are injected, the time required for removing the nucleus of the oocyte takes about 1-3 hours before the somatic cells are injected. However, since the somatic cell implantation process is performed immediately after the removal of the nucleus of the oocyte, the time can be shortened to one minute.

아울러, 단계 ⅲ)에 있어서 상기 전기적 자극은 1.0 내지 1.2 ㎸/㎝, 30 ㎲로 2회 시행하는 것이 바람직하다.In addition, in step iii), it is preferable that the electric stimulation is performed twice at 1.0 to 1.2 kV / cm and 30 μs.

상기 ⅰ), ⅱ) 단계에서 핵이 제거된 난자의 위란강에 주입된 체세포를 본 단계에서 전기적 자극으로 난자와 체세포를 융합시키며(Poleajaeva, IA.et al.,Nature, 2000, 407:86-90; Betthauser, J.et al.,Nat. Biotechnol., 2000, 18:1055-1059; Park, KW.et al.,Anim. Biotechnol., 2001, 12:173-181), 융합 후에는 전기적 자극 또는 화학적 자극을 통하여 복제란의 활성화를 유도할 수 있다.In this step, the somatic cells injected into the proliferation of the oocyte-free oocyte are fused with an electric stimulus (Poleajaeva, IA. Et al ., Nature , 2000, 407: , 2002, 12: 173-181). After fusion, the electrical stimulation was observed in the presence of an electrical stimulus (see, for example, Beththauser, J. et al ., Nat. Biotechnol ., 2000, 18: 1055-1059; Park, KW et al ., Anim. Biotechnol . Or chemical stimulation to induce activation of the cloned cells.

본 발명의 복제란 제조방법은 체세포의 핵이식 과정 등을 단순화함으로써 복제 과정을 단순화시킬 뿐만 아니라 그 생산효율을 증진시키는 것으로 그 특징은 다음과 같다.The replication method of the present invention not only simplifies the replication process by simplifying the nuclear transfer process of somatic cells, but also promotes its production efficiency.

첫째, 난자의 핵을 제거할 때 종래에 일반적으로 사용되는 형광염색을 위한 DNA 특이 형광물질을 사용하지 아니하며, 상기 방법으로도 높은 제핵률을 나타낸다. 일반적으로 난자의 핵을 제거할 때는 종래에는 통상적으로 DNA 특이 형광염색 물질인 헥스트를 널리 사용하여 왔다. 그러나, DNA가 염색된 형광염색체는 난자에 악영향을 줄 수 있으며(Tao, T.et al., Zygote, 2000, 8:69-77), 또한 상기 형광염색체를 검사하기 위하여 조사되는 자외선 또한 난자에 영향을 미칠 수 있다고 알려져 있다. 본 발명에서는 상기 과정을 생략하면서도 난자로부터 효율적으로 핵을 제거시킨다.First, when removing the nucleus of the oocyte, a DNA specific fluorescent material for fluorescent dye generally used conventionally is not used, and the nucleation rate is also high by the above method. In general, when removing the nucleus of an egg, conventionally, a DNA-specific fluorescent dye material has been widely used. However, a fluorescent chromosome stained with DNA can adversely affect the oocyte (Tao, T. et al., Zygote , 2000, 8: 69-77), and ultraviolet light irradiated to examine the fluorescent chromosome It is known that it can affect. In the present invention, the nucleus is efficiently removed from the egg while omitting the above process.

둘째, 난자의 핵을 제거한 후 바로 체세포를 주입한다. 종래에는 일반적으로 먼저 전체 난자의 핵을 하나씩 제거하여 모든 난자의 핵을 제거한 후, 체세포를 주입하였다. 상기 제핵 방법은 체세포 주입시에 난자의 제핵시에 생성된 구멍을 다시 찾아야 하며, 만일 체세포 주입을 위하여 난자에 새로운 구멍을 만든다면 제핵시에 형성된 구멍을 통하여 난자의 세포질 성분이 유출될 위험이 있으므로, 일반적으로 제핵시에 생성된 구멍을 통하여 체세포를 주입하였다. 이때, 난자에서 제핵시의 구멍을 찾는 것은 쉽지 않아 상당한 시간을 필요로 할 뿐만 아니라 복제란에게도 상당한 스트레스를 주게 된다. 따라서, 100개 이상의 다량의 복제란을 제조하는 경우에, 본 발명에서와 같은 제핵 후에 바로 체세포를 주입하는 방법은 상기와 같은 불편을 덜어주고, 상당한 시간을 절약할 수 있다.Second, somatic cells are injected immediately after oocyte nucleus is removed. Conventionally, the nuclei of whole oocytes were first removed one by one to remove the nuclei of all the oocytes, and somatic cells were injected. The nucleus method requires that the pores generated in the nucleus of the oocyte are recomputed when the somatic cells are injected. If a new hole is made in the oocyte for the somatic cell implantation, the cytoplasmic component of the oocyte may be leaked through the hole formed in the nucleus , Somatic cells were injected through the pores produced during the nucleus. At this time, it is not easy to find holes in the nucleus in the oocyte, and it takes considerable time, and also gives considerable stress to the clone. Therefore, in the case of producing more than 100 replicates, the method of injecting somatic cells immediately after the nucleus as in the present invention alleviates the inconvenience described above and can save a considerable amount of time.

셋째, 한번의 전기 충격으로 세포융합과 활성화를 유도한다. 핵이식란에서 난자와 체세포는 일반적으로 전기적 자극으로 세포융합된다(Poleajaeva, IA.et al.,Nature, 2000, 407:86-90; Betthauser, J.et al.,Nat. Biotechnol., 2000, 18:1055-1059; Park, KW.et al.,Anim. Biotechnol., 2001, 12:173-181). 상기 세포융합 후 일정 시간이 경과한 후에 또 한번의 전기적 자극 또는 화학적 자극을 통하여 복제란의 활성화를 유도하는데(Poleajaeva, IA.et al.,Nature, 2000, 407:86-90; Betthauser, J.et al.,Nat. Biotechnol., 2000, 18:1055-1059), 종래에는 이러한 세포융합 후 부가적인 활성화를 유도하는 경우에 배반포("수정란이 수회의 분할을 거쳐 세포수가 증가하고 포배강이 형성되어 자궁에 착상되기 전 단계"를 가리킨다)까지의 발생률은 7 내지 10%가 일반적이다(Betthauser, J.et al.,Nat. Biotechnol., 2000, 18:1055-1059; Koo, D-B.et al., Biol Reprod., 2000, 63:986-992). 그러나, 본 발명에서는 활성화 자극을 주지 않더라도 배반포까지의 발생률이 14.6 내지 16.6%로 높은 발생률을 나타낸다(도 1참조). 본 발명에 있어서, 종래기술과 같이 융합 후 1 내지 2시간의 추가적인 전기적 자극에 의한 배반포까지의 발생률은 상기 발생률과 큰 차이를 나타내지 아니하였다.Third, it induces cell fusion and activation by a single electric shock. In nuclear transfer embryos, oocytes and somatic cells are generally cell fusion by electrical stimulation (Poleajaeva, IA. Et al ., Nature , 2000, 407: 86-90; Betthauser, J. et al ., Nat. Biotechnol ., 2000, 18 : 1055-1059; Park, KW et al ., Anim. Biotechnol ., 2001, 12: 173-181). After a lapse of a certain period of time after the cell fusion, activation of the replicase is induced through another electrical stimulation or chemical stimulation (Poleajaeva, IA. Et al ., Nature , 2000, 407: 86-90; Betthauser, J. et al . et al, Nat Biotechnol, 2000, 18:... 1055-1059), conventionally, the number of cells increased after the blastocyst ( "embryos are divided several times in the case of inducing additional active after such fusion cells to form and contains baegang (Pre-implantation in the uterus) is generally 7 to 10% (Betthauser, J. et al ., Nat. Biotechnol ., 2000, 18: 1055-1059; Koo, DB. Et al , & Lt; / RTI > Biol Reprod ., 2000, 63: 986-992). However, in the present invention, the incidence rate to the blastocyst is as high as 14.6 to 16.6% even if no stimulation is given (see Fig . 1 ). In the present invention, as in the prior art, the incidence rate to the blastocyst by the additional electrical stimulation of 1 to 2 hours after fusion did not show a large difference from the incidence.

이러한 복제 과정의 단순화는 난자 및 복제란의 체외조작 시간을 극소화할 뿐만 아니라 형광염색 및 복제란의 활성화를 위한 추가적인 자극을 없앰으로써 난자 및 복제란에 미치는 자극을 최소화하는 이점이 있다. 또한, 복제란에 미치는손상의 최소화와 더불어 복제란 제조자의 노동시간을 감소시켜 제조자의 피로 등에 의한 복제란의 제조 효율의 감소를 최소화하는 부가적 효과도 발생된다.This simplification of the replication process has the advantage of minimizing stimulation on the oocyte and the replication field by not only minimizing the in vitro manipulation time of the oocyte and the cloning site, but also eliminating the additional stimulation for activation of the fluorescence staining and replication field. In addition, with the minimization of the damage to the replication field, there is an additional effect of minimizing the reduction of the manufacturing efficiency of the replication field due to fatigue of the manufacturer by reducing the working hours of the manufacturer of replication.

이하, 본 발명을 실시예에 의해 상세히 설명한다.Hereinafter, the present invention will be described in detail with reference to examples.

단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실시예에 한정되는 것은 아니다.However, the following examples are illustrative of the present invention, and the present invention is not limited to the following examples.

<실시예 1> 난자의 채취Example 1: Collection of oocytes

도축장에서 미경산돈의 난소를 채취하여 35 내지 39℃, 0.9% 생리적 식염수에 보관하였다. 10 ㎖ 주사기에 18 게이지 바늘을 연결하여 상기 난소의 직경 2 내지 6 ㎜ 난포에서 난포액을 흡입하여 난자를 채취하였다. 상기 난자를 성숙배양액에서 세척하고, 500 ㎕ 배양액에 50 내지 60개의 난자를 넣어 42 내지 46시간 동안 배양하였다.The ovaries of ginseng were collected from slaughterhouses and stored at 35 to 39 ° C in 0.9% physiological saline. An 18-gauge needle was connected to a 10-ml syringe and follicular fluid was inhaled in the ovarian follicles 2 to 6 mm in diameter to collect eggs. The oocytes were washed in a mature culture medium, and 50 to 60 oocytes were added to 500 쨉 l culture medium and cultured for 42 to 46 hours.

이때, 상기 성숙 배양액은 TCM 199(31100035; Gibco, Grand Island, NY)에 0.1% 폴리비닐알콜(polyvinyalcohol), 3.05 mM 포도당(D-glucose), 0.91 mM 소듐피루베이트(sodium pyruvate), 0.57 mM 시스테인(cysteine), 0.5 ㎍/㎖ LH(Sigma Chemical Co. St. Louis, MO), 0.5 ㎍/㎖ FSH(Sigma), 10 ng/㎖ 표피성장인자(epidermal growth factor, Sigma), 75 ㎍/㎖ 페니실린 G 및 50 ㎍/㎖ 스트렙토마이신을 첨가하여 제조되었다.At this time, the mature culture solution was added to 0.1% polyvinyalcohol, 3.05 mM glucose, 0.91 mM sodium pyruvate, 0.57 mM cysteine, (Sigma), 0.5 g / ml FSH (Sigma), 10 ng / ml epidermal growth factor (Sigma), 75 占 퐂 / ml penicillin G and 50 [mu] g / ml streptomycin.

<실시예 2> 체세포의 배양Example 2: Culture of somatic cells

임신 30 내지 35일 된 임신돈을 도축하여 돼지 태아를 체취한 후 얼음에 넣어 실험실로 운반했다. 돼지태아를 가위로 잘게 자른 후, 돼지 체세포를 0.05% 트립신 및 0.5 mM EDTA가 첨가된 PBS(phosphate buffered saline; 인산완충식염수)에서 30분간 배양하였다. 원심분리로 상층액을 제거한 후, 10% FCS(fetal calf serum)가 포함된 DMEM(Dulbecco's modifided Eagle medium) 배양액(BioWhittaker)에서 2-3일간 배양하였다. 바닥의 80%를 세포가 덮을 때까지(80% confluency) 배양시킨 후, 트립신 처리 후 계대배양하여 세포의 일부는 핵이식에 이용하고 나머지 세포는 동결 보존하였다.The pregnant pigs were slaughtered between 30 and 35 days of gestation and the pig embryos were picked and placed on ice for transportation to the laboratory. Porcine embryos were cut with scissors and pig somatic cells were cultured in PBS (phosphate buffered saline) supplemented with 0.05% trypsin and 0.5 mM EDTA for 30 minutes. The supernatant was removed by centrifugation and then cultured in DMEM (Dulbecco's modifed Eagle medium) containing 10% fetal calf serum (BioWhittaker) for 2-3 days. After 80% confluency of the bottom (80% confluency), the cells were subcultured by trypsinization, and some of the cells were used for nuclear transfer and the remaining cells were cryopreserved.

<실시예 3> 미세조작(micromanipulation)&Lt; Example 3 > Micro-manipulation (micromanipulation)

실시예 1에서 채취된 난자를 미세조작용 배양액에서 5 내지 10 분간 배양한 후, 실시예 2에서 배양된 체세포를 상기 배양액에 첨가하였다. 이때, 미세조작용 배양액은 TCM 199에 0.3% BSA 및 7.5 ㎍/㎖ CB(cytochalasin B)를 첨가하여 제조되었다.The oocytes collected in Example 1 were cultured for 5 to 10 minutes in the micronutrient broth, and the somatic cells cultured in Example 2 were added to the culture broth. At this time, the microorganism culture broth was prepared by adding 0.3% BSA and 7.5 / / ml CB (cytochalasin B) to TCM 199.

난자의 핵을 제거하기 위하여, 선단이 30-60°로 날카롭게 연마된 직경 30 ㎛의 미세유리관을 준비하였다. 먼저 난자의 극체를 1시 방향으로 고정시키고, 상기 미세유리관을 극체가 있는 방향으로 찔러 넣었다. 유압을 이용하여 극체와 극체 주위의 세포질을 약 10-20% 정도 흡입하였고, 대부분의 핵은 극체 주위에 위치해 있으므로 상기 과정에서 대부분의 난자의 핵이 제거되었다. 그 후에 상기 미세유리관을 이용하여 실시예 2에서 제조된 돼지 체세포를 흡입하고 상기 미세유리관을 핵이 제거된 난자의 위란강에 위치시킨 후 유압을 이용하여 체세포를 난자의 위란강에 주입시켰다(도 1).To remove the oocyte nuclei, a micro-glass tube having a diameter of 30 탆 and sharpened at a tip of 30-60 ° was prepared. First, the oocyte's polar body was fixed at 1 o'clock, and the micro-glass tube was stuck in the polar body direction. Most of the oocyte nuclei were removed in the process because most of the nuclei were located around the polar body, using the hydraulic pressure to inhale the cytoplasm around the polar body and the polar body. Thereafter was sucks the porcine somatic cells prepared in Example 2 using the fine glass tube was charged with the somatic cell by using a hydraulic After placing the wiran steel of the oocyte nucleus is removed, the fine glass tube to wiran steel of the egg (Fig. 1 ).

<실시예 4> 난자 핵의 염색Example 4 Dyeing of oocyte nuclei

상기 실시예 3 이후에 참고적으로 난자의 제핵 정도를 확인하기 위하여, 일부 난자는 핵을 제거시킨 후 체세포를 주입하지 않고 헥스트 33342(Sigma)로 형광염색하여 제핵률을 검사하였다(도 2).In order to confirm the degree of the nucleus of the oocyte after the above Example 3, some oocytes were subjected to fluorescence staining with Hest 33342 (Sigma) after eliminating the nuclei without injecting somatic cells ( FIG. 2 ) .

이것은 종래 기술에서 제핵에 앞서서 형광염색하는 것과는 달리, 본 발명에서는 제핵이 완료된 후 제핵 정도를 판별하기 위하여 형광염색을 하였다. 그 결과, 제핵률은 350번의 반복 시행에서 86.3%에 이르렀으므로, 본 발명의 방법을 사용함으로써 제핵에 앞서서 형광염색을 이용하지 않고서도 높은 효율로 난자로부터 핵을 제거시킬 수 있음을 확인하였다. 따라서, 이후의 실시에서는 전혀 형광염색 없이 실시예 3의 제핵 후, 바로 실시예 5의 단계를 수행하였다.This is different from fluorescence staining prior to the nucleus in the prior art. In the present invention, after completion of the nucleus, fluorescence staining was performed to discriminate the degree of the nucleus. As a result, it was confirmed that the nucleation rate was 86.3% in 350 repetitions, so that it was possible to remove the nucleus from the oocyte with high efficiency without using fluorescence staining before the nucleus by using the method of the present invention. Thus, in the following example, the steps of Example 5 were followed immediately after the nucleotide of Example 3 without any fluorescent staining.

<실시예 5> 세포융합, 활성화 및 복제란의 배양&Lt; Example 5 > Culture of cell fusion, activation and replication

<5-1> 세포융합 및 활성화<5-1> Cell fusion and activation

실시예 3의 미세조작이 끝나면 핵이식란을 활성화 배양액에 넣은 후 간격이 1 ㎜ 떨어진 백금 전기선 사이에 난자-체세포 복합체를 위치시키고, 융합기(BTX Electro-Cell Manipulation 2001)로 1.0 내지 1.2 ㎸/㎝, 30 ㎲의 DC 펄스를 2회가하여 세포융합 및 활성화를 유도하였다. 전기 자극을 가한 후 0.5 내지 1시간 후에 융합률을 검사하였다. 이때, 미세조작을 하지 않은 난자에 동일 조건의 전기 자극을 준 경우를 대조군으로 설정하였으며, 상기 활성화 배양액은 0.3 M 만니톨(mannitol)에 1 mM CaCl2ㆍH2O, 0.1 mM MgCl2ㆍ6H2O 및 0.5M HEPES 완충액을 첨가하여 제조되었다.When the micro-manipulation of Example 3 was completed, the oocyte-somatic cell complex was placed between the platinum wire lines spaced 1 mm apart after inserting the nuclear transfer embryos into the activation culture medium, and a 1.0 to 1.2 kV / cm , And a DC pulse of 30 를 was added twice to induce cell fusion and activation. Fusion rates were checked 0.5 to 1 hour after the electrical stimulation. At this time, the control group was set as a control group when the same stimulation was given to the oocytes that were not subjected to the micro-manipulation. To the 0.3 M mannitol, 1 mM CaCl 2 .H 2 O, 0.1 mM MgCl 2 .6H 2 O &lt; / RTI &gt; and 0.5 M HEPES buffer.

<5-2> 복제란의 배양 및 발생<5-2> Cultivation and occurrence of replication column

실시예 <5-1>에서 제조된 융합 복제란을 선별한 후, 500 ㎕의 발생 배양액이 들어 있는 4-웰 용기에서 20 내지 30개의 복제란을 6일 동안 배양하였다. 배양완료 후에 5 ㎍/㎖의 헥스트 33342로 염색하고, 형광현미경 하에서 복제란과 단위 발생란("난자가 수정현상을 거치지 않고 외부의 자극에 의해 활성화되어 수정란과 동일하게 난분할을 하는 난"을 가리킨다)의 핵수를 검사하였다. 이때, 미세조작을 하지 않은 단위 발생란을 동일한 방법으로 배양한 경우를 대조군으로 설정하였으며, 상기 발생 배양액은 NCSU-23(북캐롤리나주립대-23; Petters, RM. and Wells, KD.,J. Reprod. Fertil. Suppl., 1993, 48:61-73) 배지에 0.4% BSA를 첨가하여 제조되었다.After the fusion clone prepared in Example <5-1> was selected, 20 to 30 clones were cultured in a 4-well container containing 500 μl of the development medium for 6 days. After completion of the incubation, the cells were stained with 5 쨉 g / ml of Hest 33342, and under the fluorescence microscope, the clone and the unit cell ("the egg is activated by the external stimulus without the modification, ) Were examined. In this case, the case where the microorganisms were cultured by the same method was set as a control group. The culture medium was NCSU-23 (North Carolina State University -23; Petters, RM and Wells, KD., J. Reprod. Fertil. Suppl. , 1993, 48: 61-73) supplemented with 0.4% BSA.

그 결과, 1.0 ㎸/㎝ 전기 자극 처리군이 66.1%, 1.1 ㎸/㎝ 처리군이 81.5%, 그리고 1.2 ㎸/㎝ 처리군이 78.5%의 융합률을 나타내어, 상대적으로 1.0 ㎸/㎝ 처리군의 융합률이 유의적으로 낮았다. 그러나, 분할률에서는 67.2 내지 68.6%, 배반포 생산률에서는 14.6 내지 16.6%, 그리고 배반포 세포수에서는 22.1 내지 24.5로 나타나, 전압을 달리한 처리구 사이에서 차이를 나타내지 않았다(표 1)As a result, the fusion rate of 1.0 ㎸ / ㎝ electric stimulation group was 66.1%, that of 1.1 ㎸ / ㎝ treated group was 81.5%, and that of 1.2 ㎸ / ㎝ treated group was 78.5% Fusion rate was significantly lower. However, the fractionation rate was 67.2 to 68.6%, the blastocyst production rate was 14.6 to 16.6%, and the blastocyst cell number was 22.1 to 24.5, showing no difference between treatments with different voltages ( Table 1 )

세포융합 및 활성화를 위한 전기 자극이 복제란의 발생에 미치는 영향Effect of electrical stimulation for cell fusion and activation on the development of cloned cells 처리process 전압(㎸/㎝)Voltage (kV / cm) 난자의 수Number of eggs 융합률(%)Fusion rate (%) 분할률(%)Partitioning rate (%) 배반포 발생률(%)Incidence of blastocyst (%) 배반포 생산수(범위)Number of blastocyst production (range) 대조군Control group 1.01.0 118118 68.4 ±5.568.4 ± 5.5 17.4 ±2.517.4 ± 2.5 26.3 ±2.3 (13-54)26.3 ± 2.3 (13-54) 1.11.1 141141 84.0 ±5.084.0 ± 5.0 12.7 ±2.312.7 ± 2.3 25.3 ±2.5 (26-56)25.3 ± 2.5 (26-56) 1.21.2 230230 75.2 ±4.175.2 ± 4.1 19.9 ±1.919.9 ± 1.9 27.9 ±1.6 (14-68)27.9 ± 1.6 (14-68) 핵이식란Nuclear transfer 1.01.0 190190 66.1 ±3.166.1 ± 3.1 67.6 ±5.067.6 ± 5.0 16.6 ±2.316.6 ± 2.3 22.1 ±2.3 (17-38)22.1 ± 2.3 (17-38) 1.11.1 224224 81.5 ±3.181.5 ± 3.1 68.6 ±5.068.6 ± 5.0 15.8 ±2.315.8 ± 2.3 23.8 ±2.0 (10-40)23.8 ± 2.0 (10-40) 1.21.2 299299 78.5 ±2.778.5 ± 2.7 67.2 ±4.367.2 ± 4.3 14.6 ±2.014.6 ± 2.0 24.5 ±1.9 (14-41)24.5 ± 1.9 (14-41)

상기표 1에서,In Table 1 ,

, ,

, ,

을 나타낸다. .

상기 결과로부터, 본 발명의 복제란 제조방법은 종래의 방법에 비하여 융합률 및 분할률이 현저히 높음을 알 수 있으며, 따라서 융합 유무를 확인하기 위한 핵염색 과정을 생략할 수 있음을 확인하였다.From the above results, it can be seen that the method of producing the clone of the present invention has a significantly higher fusion rate and fractionation rate than the conventional method, and thus it is possible to omit the nuclear staining procedure to confirm the presence or absence of fusion.

상기에서 살펴본 바와 같이, 본 발명의 복제란 제조방법은 돼지의 복제 과정을 단순화하여 고효율의 복제란을 제조할 수 있으므로, 본 발명의 방법은 멸종위기 동물의 보존, 유용 단백질의 생산, 질환 모델의 개발 및 부족한 장기의 공급 등을 위한 복제란의 제조에 유용하게 사용될 수 있다.As described above, since the replication method of the present invention can simplify the cloning process of pigs and produce a highly efficient clone, the method of the present invention can be used for preservation of endangered animals, production of useful protein, And can be usefully used for the production of replication fields for development and supply of deficient organs.

Claims (9)

ⅰ) 난자의 핵을 염색하지 않고 제 1 극체와 10 내지 20%의 세포질을 흡입하여 난자의 핵을 제거하는 단계;I) removing the nucleus of the oocyte by inhaling the first polar body and 10-20% of the cytoplasm without staining the nucleus of the oocyte; ⅱ) 제 1 극체와 핵을 제거한 상기 난자의 위란강에 체세포를 주입하여 난자-체세포 복합체를 제조하는 단계; 및Ii) injecting a somatic cell into the proliferation of the oocyte in which the first polar body and the nucleus are removed to prepare an oocyte-somatic cell complex; And ⅲ) 0.5 내지 2 ㎸/㎝, 6 내지 150 ㎲로 1 내지 3회 시행하는 전기적 자극으로 상기 난자-체세포 복합체를 세포융합 및 활성화시키는 단계를 포함하는, 동물의 복제란 제조방법.Iii) cell fusion and activation of said oocyte-somatic cell complex with an electrical stimulation carried out 1 to 3 times at 0.5 to 2 kV / cm, 6 to 150 μs. 제 1항에 있어서, 단계 ⅰ)의 흡입은 직경 20-40 ㎛, 30-60°의 선단 구조인 유리관을 사용하여 유압 차를 이용하여 이루어지는 것을 특징으로 하는 제조방법.The method according to claim 1, wherein the inhalation of step i) is carried out using a hydraulic pressure differential using a glass tube having a diameter of 20-40 mu m and a tip structure of 30-60 DEG. 제 1항에 있어서, 단계 ⅰ)의 난자는 인간을 제외한 포유동물로부터 채취되는 것을 특징으로 하는 제조방법.The method according to claim 1, wherein the oocyte of step i) is collected from mammals other than humans. 제 3항에 있어서, 상기 포유동물은 돼지, 소, 산양, 생쥐, 큰쥐, 토끼, 개,고양이로 구성되는 군으로부터 선택되는 한 종인 것을 특징으로 하는 제조방법.4. The method according to claim 3, wherein the mammal is a species selected from the group consisting of pigs, cows, goats, mice, mice, rabbits, dogs, cats. 제 1항에 있어서, 상기 체세포는 인간을 제외한 포유동물로부터 채취되는 것을 특징으로 하는 제조방법.The method according to claim 1, wherein the somatic cells are collected from mammals other than humans. 제 5항에 있어서, 상기 포유동물은 돼지, 소, 산양, 생쥐, 큰쥐, 토끼, 개, 고양이로 구성되는 군으로부터 선택되는 한 종인 것을 특징으로 하는 제조방법.6. The method according to claim 5, wherein the mammal is a species selected from the group consisting of pigs, cows, goats, mice, mice, rabbits, dogs, and cats. 제 6항에 있어서, 상기 포유동물은 돼지인 것을 특징으로 하는 제조방법.7. The method of claim 6, wherein the mammal is a pig. 제 1항에 있어서, 상기 ⅰ) 단계 이후에 1분 내에 상기 체세포를 주입하는 것을 특징으로 하는 제조방법.2. The method according to claim 1, wherein the somatic cells are injected within one minute after the step (i). 제 1항에 있어서, 1.0 내지 2.0 ㎸/㎝, 30 ㎲로 2회 전기적 자극을 시행하는 것을 특징으로 하는 제조방법.The method according to claim 1, wherein electrical stimulation is performed twice at 1.0 to 2.0 kV / cm and 30 μs.
KR10-2003-0014132A 2003-03-06 2003-03-06 Method for production of cloned animal embryos by nuclear transfer KR100500412B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR10-2003-0014132A KR100500412B1 (en) 2003-03-06 2003-03-06 Method for production of cloned animal embryos by nuclear transfer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR10-2003-0014132A KR100500412B1 (en) 2003-03-06 2003-03-06 Method for production of cloned animal embryos by nuclear transfer

Publications (2)

Publication Number Publication Date
KR20040079189A true KR20040079189A (en) 2004-09-14
KR100500412B1 KR100500412B1 (en) 2005-07-12

Family

ID=37364234

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-2003-0014132A KR100500412B1 (en) 2003-03-06 2003-03-06 Method for production of cloned animal embryos by nuclear transfer

Country Status (1)

Country Link
KR (1) KR100500412B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220079749A (en) * 2020-12-04 2022-06-14 대한민국(농촌진흥청장) Method for enhancing developmental rate of porcine somatic cell nuclear transfer embryos using microRNA-29b direct injection

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106062196B (en) 2013-04-30 2020-01-21 建国大学校产业学校协力团 CMP-acetylneuraminic acid hydroxylase targeting vector, vector-transduced transgenic animal for xenotransplantation, and method for producing same
KR102055580B1 (en) 2019-07-29 2019-12-13 주식회사 엠케이바이오텍 The electric fusion needle for producing a somatic cell nuclear transfer embryo using a platinum wire easy to replace

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220079749A (en) * 2020-12-04 2022-06-14 대한민국(농촌진흥청장) Method for enhancing developmental rate of porcine somatic cell nuclear transfer embryos using microRNA-29b direct injection

Also Published As

Publication number Publication date
KR100500412B1 (en) 2005-07-12

Similar Documents

Publication Publication Date Title
JP4997510B2 (en) Method for producing fish embryo
EP0919121A1 (en) In vivo electroporation method for early animal embryo
US20190032086A1 (en) Method for preparing a gene knock-out canine with somatic cell cloning technology
KR100417566B1 (en) A mass production method of embryos by nuclear transfer using somatic cells
KR100807644B1 (en) Piglet production method by simultaneous transfer of embryos formed by in vitro fertilization and nuclear transfer
US7799969B2 (en) Methods for cloning rats by nuclear transfer
KR100500412B1 (en) Method for production of cloned animal embryos by nuclear transfer
DiBerardino Genomic multipotentiality of differentiated somatic cells
US20120142107A1 (en) Method and system for somatic cell nuclear transfer
JP2002511234A (en) Swine nuclear transfer
KR20080077738A (en) A methods to improve in vitro maturation of pig oocytes
KR100479704B1 (en) Method of producing a transgenic pig expressing green fluorescent protein
US20050149999A1 (en) Methods for cloning mammals using remodeling factors
KR100860082B1 (en) The massproduction method of mammalian embryos by treatment of Prostacyclin analog
KR100502480B1 (en) Method of producing porcine clonal somatic cell line expressing green fluorescent protein
CN100526456C (en) Method for transplanting consubstantial cell nucleus
JP4119513B2 (en) How to make cloned animals
KR101107329B1 (en) A composition for culturing mammalian embryos and a method for mass production of mammalian embryos using thereof
KR20090115081A (en) Cloning Method Of Canids
KR20070089097A (en) Dual pipet and method for enucleation, nuclear transplantation and somatic animal clon production by using the same
JP4696235B2 (en) Method for producing fish embryo
KR100868245B1 (en) Effective producing method of cloned animal by demecolcine treatment
CN111718962A (en) Method for preparing cloned cat by somatic cell cloning
CN115960958A (en) Genetic modification method for changing hair color of cat
KR20040065214A (en) Preparing somatic embryo by utilizing rabbit oocyte

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20130701

Year of fee payment: 9

FPAY Annual fee payment

Payment date: 20140630

Year of fee payment: 10

FPAY Annual fee payment

Payment date: 20160630

Year of fee payment: 12

FPAY Annual fee payment

Payment date: 20170626

Year of fee payment: 13

FPAY Annual fee payment

Payment date: 20180702

Year of fee payment: 14

FPAY Annual fee payment

Payment date: 20190422

Year of fee payment: 15